Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
An international team of researchers has uncovered evidence of partial resistance to artemisinin derivatives -- the primary treatment for malaria -- in young children with severe malaria.
A recent study by Heidelberg University Hospital in Germany has highlighted the high global cost of oral diseases, such as tooth decay, gum disease, and tooth loss. These conditions cost the world ...